Medtronic plc (MDT)

NYQ – Real vaqt narxi. Valyuta: USD

90.72

+0.04 (0.04%)

Bozor ochiq: Aug 12, 2026, 3:25 PM EDT

90.50

-0.18 (-0.20%)

Oldingi bozordan keyin: Aug 11, 2026, 7:58 PM EDT

10.08.2026

Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know

In the closing of the recent trading day, Medtronic (MDT) stood at $89.41, denoting a +2.58% move from the preceding trading day.

10.08.2026

Medtronic: Buy This Undervalued Dividend Aristocrat Before The Market Catches On

Medtronic is rated 'Buy' for its compelling combination of income, growth, and value. MDT's growth is led by cardiac ablation with 124% U.S. segment growth and rapid expansion of the Hugo robotic surgery platform. Management guides for 11.75% organic revenue growth in Q1 2027, with CAS expected to outpace the market and Symplicity renal denervation gaining traction.

10.08.2026

We Said These 4 Dividend Aristocrats Could Soar. Here's How They Did, Plus 3 New Picks.

About a year ago, 24/7 Wall St. flagged four overlooked Dividend Aristocrats as stealth growth plays, arguing that boring income names carried real upside if the market ever noticed.

08.08.2026

Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?

Medtronic has launched new devices that will help further improve its financial results. Intuitive Surgical's latest da Vinci system could expand its addressable market.

08.08.2026

I've Got Royalty on the Brain

And how could I not? After exploring Brighton Beach and Bristol, and then Cornwall all the way to St. Ives and Penzance, I wrapped up my Great Britain trip with a couple days in London.

06.08.2026

Stock Picks From Seeking Alpha's July 2026 New Analysts

Seeking Alpha welcomed 33 new analysts in July 2026. This article showcases their top picks and investment strategies. Highlighted companies include SELLAS Life Sciences, Chevron, B2Gold, Amazon, and QXO, each with detailed investment theses. Analysts emphasize asymmetric opportunities, event-driven catalysts, balance sheet strength, market structure, and sector-specific growth or risk factors.

06.08.2026

33 stocks to bet on foreign markets continuing to beat the S&P 500

Surprisingly, many foreign markets are way ahead of the U.S. in year-to-date performance.

Videolar

No Data

There is no data to display

Press-relizlar

06.08.2026

Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias

Sphere-9 all-in-one mapping and ablation, large-tip focal, dual energy catheter first to be CE Marked for ventricular ablation New indication marks important milestone for ventricular arrhythmia patients as positive physician sentiment and global expansion for Sphere ‑ 9 continue Sphere VT U.S. pivotal trial enrollment underway GALWAY, Ireland, Aug. 6, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced an expanded CE Mark indication for the Affera™ Mapping and Ablation System with Sphere-9™ Catheter to treat ventricular arrhythmias, including ventricular tachycardia (VT) and premature ventricular complexes (PVCs). The Sphere-9 catheter is the first all-in-one mapping and ablation, large-tip focal, dual-energy catheter CE marked for ventricular ablation.

Medtronic plc (MDT)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Medtronic plc (MDT)

Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know

Medtronic: Buy This Undervalued Dividend Aristocrat Before The Market Catches On

We Said These 4 Dividend Aristocrats Could Soar. Here's How They Did, Plus 3 New Picks.

Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?

I've Got Royalty on the Brain

Stock Picks From Seeking Alpha's July 2026 New Analysts

33 stocks to bet on foreign markets continuing to beat the S&P 500

Videolar

No Data

Press-relizlar

Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias

Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know

Medtronic: Buy This Undervalued Dividend Aristocrat Before The Market Catches On

We Said These 4 Dividend Aristocrats Could Soar. Here's How They Did, Plus 3 New Picks.

Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?

I've Got Royalty on the Brain

Stock Picks From Seeking Alpha's July 2026 New Analysts

33 stocks to bet on foreign markets continuing to beat the S&P 500

Videolar

No Data

Press-relizlar

Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias

Search stocks

Medtronic plc (MDT)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Medtronic plc (MDT)

Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know

Medtronic: Buy This Undervalued Dividend Aristocrat Before The Market Catches On

We Said These 4 Dividend Aristocrats Could Soar. Here's How They Did, Plus 3 New Picks.

Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?

I've Got Royalty on the Brain

Stock Picks From Seeking Alpha's July 2026 New Analysts

33 stocks to bet on foreign markets continuing to beat the S&P 500

Videolar

No Data

Press-relizlar

Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias

Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know

Medtronic: Buy This Undervalued Dividend Aristocrat Before The Market Catches On

We Said These 4 Dividend Aristocrats Could Soar. Here's How They Did, Plus 3 New Picks.

Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?

I've Got Royalty on the Brain

Stock Picks From Seeking Alpha's July 2026 New Analysts

33 stocks to bet on foreign markets continuing to beat the S&P 500

Videolar

No Data

Press-relizlar

Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias